Physician profile
Zeke Walton
NPI 1780844563
$18,991.66
in general payments reported to CMS, 2019-2025
10 companies · $17K in 2025
The $17K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $150 · 2023: $39.60 · 2024: $1,791 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $2,201 · Food and Beverage: $2,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,500.00 |
| Travel and Lodging | $2,200.80 |
| Food and Beverage | $2,141.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $15,666.35 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $1,713.91 | 2025 | Persona |
| Stryker Corporation | $859.04 | 2024-2025 | Mako, Insignia, Gmrs |
| Kerecis Limited | $238.66 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Onkos Surgical, INC. | $234.04 | 2024-2025 | Eleos Limb Salvage System |
| Smith+Nephew, INC. | $149.56 | 2020 | |
| Depuy Synthes Sales INC. | $41.33 | 2024 | Tfn-Advance, Fibergraft Aeridyan Matrix |
| Davol INC. | $39.60 | 2023 | |
| Becton, Dickinson and Company | $29.74 | 2024-2025 | Hemosphere |
| Acera Surgical, INC. | $19.43 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zeke Walton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.